COLUMBIA, Md.--(BUSINESS WIRE)--Osiris Therapeutics, Inc. (NASDAQ: OSIR) today announced the appointment of Stephen W. Potter as Senior Vice President of Operations and Corporate Development, reporting directly to C. Randal Mills, Ph.D., President and Chief Executive Officer. Mr. Potter has more than 20 years of life science management experience, most recently as Senior Vice President of Corporate and Business Development at Genzyme Corporation.
